Recent News

• 03.26.2026 - COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
• 03.24.2026 - CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement
• 03.18.2026 - CollPlant Biotechnologies Launches Redesigned Corporate Website
• 03.11.2026 - COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS
• 02.26.2026 - CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler
• 02.23.2026 - CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex

Recent Filings

• 03.24.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 03.24.2026 - EX-99.1 EX-99.1
• 03.19.2026 - 3 Initial statement of beneficial ownership of securities
• 03.18.2026 - 3 Initial statement of beneficial ownership of securities
• 03.18.2026 - 3 Initial statement of beneficial ownership of securities
• 03.18.2026 - 3 Initial statement of beneficial ownership of securities
• 03.18.2026 - 3 Initial statement of beneficial ownership of securities
• 03.18.2026 - 3 Initial statement of beneficial ownership of securities
• 03.18.2026 - 3 Initial statement of beneficial ownership of securities
• 03.18.2026 - 3 Initial statement of beneficial ownership of securities